Contraindicated (one)bortezomib will raise the level or influence of mavacamten by influencing hepatic enzyme CYP2C19 metabolism. Contraindicated. Powerful or moderate CYP2C19 inhibitors could maximize mavacamten systemic exposure, leading to coronary heart failure on account of systolic dysfunction. chloramphenicol will boost the stage or result of bortezomib by affecting hepatic/int... https://lordx110jvf3.shivawiki.com/user